Paul George’s 25-Game Suspension: Details on 76ers Star’s Drug Ban
The NBA announced on January 31, 2026, that Paul George had been suspended for 25 games without pay. The ban stemmed from a violation of the NBA/NBPA Anti-Drug Program.
What the league disclosed
The official release stated only a violation of the Anti-Drug Program. The NBA did not name a specific substance in its statement.
That omission leaves the public with confirmed facts but not a full explanation. Reporters and fans should avoid assuming details beyond the league’s announcement.
George’s explanation
Paul George said he took an “improper medication” while seeking treatment for a mental health issue. He accepted full responsibility and apologized to the 76ers, teammates and fans.
He did not identify the drug when addressing the matter. George later reiterated he would not publicize the substance.
Timing and financial impact
The suspension began the night it was announced, during Philadelphia’s game against the New Orleans Pelicans. He became eligible to return on March 25, 2026.
Reuters calculated the lost salary at more than $11.7 million. The financial hit reflected the 25-game absence.
Return to the lineup
George rejoined the 76ers on March 25, 2026, in a game against the Chicago Bulls. He scored 28 points in that comeback appearance.
The return gave Philadelphia an experienced wing late in the season. The club hoped he would help steady its roster down the stretch.
Season context
George was 35 years old during the 2025–26 season. He was in the second year of a four-year, $212 million deal with the 76ers.
Through 37 regular-season games that year, he averaged 17.3 points, 5.3 rebounds, and 3.6 assists. Those numbers underline why the suspension mattered to Philadelphia.
Broader implications
The case highlights limits on what leagues disclose in anti-drug investigations. The NBA named the program violation but withheld the substance name.
For clarity, the cleanest summary is simple. Paul George faced a 25-game suspension under the NBA/NBPA Anti-Drug Program, with no public naming of the drug involved.
Filmogaz.com will continue following developments and report any official updates.
